Gennova Biopharmaceuticals Ltd., headquartered in Pune, India, is a biotechnology company dedicated to developing, producing, and commercializing biotherapeutics to address life-threatening diseases across various indications. Gennova is successfully commercializing bio-therapeutics across cardiovascular, neurology, nephrology, and oncology segments with seven products; 5 biosimilars, one generic, and one pioneering 'first-in-the-world' product.Gennova's socio-economic responsibility has established itself as a preferred research and cGMP manufacturing partner in the area of vaccine development to address some of the world's most challenging diseases like Covid-19, malaria, Leishmania, flu, etc.Gennova launched Indias first mRNA-based vaccine against COVID-19 GEMCOVAC-19and got the EUA approval in India. Gennova aspires to transform millions of people's healthcare, primarily through advanced technological solutions.